fNIRS reveals comparable reductions in cortical hyperconnectivity following once-daily and twice-daily rTMS in poststroke aphasia

fNIRS显示,卒中后失语症患者接受每日一次和每日两次rTMS治疗后,皮质过度连接性均有类似的降低。

阅读:1

Abstract

In clinical practice, there is a common assumption that more frequent intervention yields better outcomes for patients with post-stroke aphasia (PSA). This study investigated this by comparing the efficacy of once-daily versus twice-daily low-frequency repetitive transcranial magnetic stimulation (rTMS). In this non-randomized trial, 40 PSA patients self-selected into once-daily (n = 20) or twice-daily (n = 20) 1 Hz rTMS groups targeting the right Broca's area for three weeks, alongside 26 healthy controls. Functional near-infrared spectroscopy (fNIRS) assessed oxygenated hemoglobin-based functional connectivity (FC) during a verbal fluency task pre- and post-intervention. Data were analyzed using repeated-measures ANOVA. Pre-intervention, PSA patients exhibited maladaptive cortical hyperconnectivity. Following rTMS, both groups showed comparable improvement in aphasia quotient scores, with no significant between-group differences. Analysis of fNIRS data showed that both once-daily and twice-daily rTMS regimens led to a clear reduction in the count of strong FC edges, accompanied by an overall decrease in global mean FC following intervention. Notably, reductions in global mean FC were more pronounced in the twice-daily group, whereas only modest changes were observed following once-daily stimulation. Overall, both low-frequency rTMS regimens effectively attenuated maladaptive cortical hyperconnectivity in poststroke aphasia, supporting their role in network normalization. Importantly, the absence of a clear advantage for twice-daily stimulation challenges the "more is better" paradigm and highlights the potential value of individualized and cost-effective treatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。